Aura Biosciences, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $-87.4M | — |
| FY2020 | — | $-108.7M | $17.4M |
| FY2021 | — | $152.3M | $149.1M |
| FY2022 | — | $195.6M | $121.6M |
| FY2023 | — | $225.8M | $41.1M |
| FY2024 | — | $152.0M | $31.7M |
| FY2025 | — | $136.9M | $59.5M |